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Aims
Leber congenital amaurosis (LCA) is the earliest and most
severe retinal dystrophy. It occurs as non-syndromic or
syndromic. 26/37 LCA genes are important to ciliary func-
tion and account for < 1/3 of cases. These cases develop-
or are at risk to develop- skeletal, renal and/or neurologic
symptoms. Here, we assessed efficiency of ciliome rese-
quencing (CR) as a tool for molecular diagnosis and
patient care.
Patients and methods
The DNA of 60 unrelated young children with LCA was
screened for mutations using a custom 5.3 Mb Agilent
SureSelect Target Enrichment library which captures
32,146 exons of 1,666 genes selected form cilia databases.
Segregation analysis of rare candidate variants was
performed by Sanger sequencing.
Results
Biallelic disease-causing mutations in known genes were
identified in 17/60 patients (30 %): CEP290 (n = 4),
CRB1 (n = 4), RPGRIP1 (n = 2), LCA5 (n = 1), IQCB1
(n = 2), IFT140 (n = 2), AHI1 (n = 1), ALMS1 (n = 1).
In addition, 3/60 patients harbored biallelic mutations in
three novel genes which screening in additional non
syndromic and syndromic LCA cases allowed identifying
additional mutations in 2/3 of them.
Conclusions
The identification of mutations in known and novel
genes in 33 % of the cases, makes targeted sequencing an
interesting alternative to exome resequencing. The iden-
tification of mutations in several genes responsible for
syndromic LCA in young children with no overt extrao-
cular expression demonstrates the importance of NGS-
based molecular diagnosis to set-up a rational and
efficient follow-up of patients.
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